KEITH SHIELDS: Open Payments
NPI 1265972350 · CUMBERLAND, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 102 payments from 21 companies in 2025. Trend: 2023 $1,759 · 2024 $1,920 · 2025 $2,311
Food & beverage: $2,311
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $377 |
| ABBVIE INC. | 15 | $245 |
| Aimmune Therapeutics, Inc. | 11 | $229 |
| Novo Nordisk Inc | 7 | $181 |
| GlaxoSmithKline, LLC. | 10 | $181 |
| Exeltis, USA Inc. | 1 | $166 |
| Exact Sciences Corporation | 7 | $136 |
| Lilly USA, LLC | 4 | $116 |
| Amgen Inc. | 4 | $100 |
| Astellas Pharma US Inc | 3 | $91 |
Products named: FARXIGA, SLYND, BREZTRI, Cologuard Collection Kit, VOWST, TRELEGY ELLIPTA, Wegovy, JARDIANCE.
Industry payments across RI — which companies pay providers there.
